Back
Monopar Therapeutics Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$33.77
Seasonality Move:
-21.14%
7 Day Trial
ALL ACCESS PASS
$
7
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.28 | Buy |
| 20-day SMA: | 33.72 | Buy |
| 50-day SMA: | 37.02 | Sell |
| 200-day SMA: | 27.44 | Buy |
| 8-day EMA: | 33.45 | Buy |
| 20-day EMA: | 34.08 | Buy |
| 50-day EMA: | 35.27 | Sell |
| 200-day EMA: | 28.42 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.83 | Sell |
| Relative Strength Index (14 RSI): | 51.51 | Buy |
| Chaikin Money Flow: | 16508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.15 - 35.73) | Buy |
| Bollinger Bands (100): | (31.58 - 42.76) | Sell |
Monopar Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.01 while MNPR 8-day simple moving average is 33.28, which is a Buy signal.
-
The stock price of MNPR is 35.01 while Monopar Therapeutics 20-day SMA is 33.72, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 37.02 while MNPR share price is 35.01, making it a Sell technically.
-
MNPR stock price is 35.01 and Monopar Therapeutics 200-day simple moving average is 27.44, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $35.01. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
214.1M
Price in USD:
35.01
Share Volume:
24.4K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 35.01 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 35.01 while MNPR 8-day exponential moving average is 33.45, which is a Buy signal.
-
The stock price of MNPR is 35.01 while Monopar Therapeutics 20-day EMA is 34.08, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 35.27 while MNPR share price is 35.01, making it a Sell technically.
-
MNPR stock price is 35.01 and Monopar Therapeutics 200-day simple moving average is 28.42, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.63 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.83, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 51.51, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (32.15 - 35.73), which suggest Monopar Therapeutics is a Sell
-
The Bollinger Bands (100) for Monopar Therapeutics is (31.58 - 42.76), which suggest Monopar Therapeutics is a Sell
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.